Genetic differences between type 1 diabetes with and without other autoimmune diseases

Area of Science:

• Immunogenetics
• Endocrinology
• Genetics

Background:

• Type 1 diabetes (T1D) patients sometimes develop multiple autoimmune diseases (ADs).
• This clustering suggests shared genetic factors influencing autoimmunity in T1D.
• Genetic differences between T1D patients with and without additional ADs are not fully understood.

Purpose of the Study:

• To investigate clinical and genetic distinctions in T1D patients.
• To compare T1D patients with systemic ADs, organ-specific ADs, and no other ADs.
• To identify specific genetic variations associated with AD clustering in T1D.

Main Methods:

• Analyzed single nucleotide polymorphisms (SNPs) in CTLA4, SUMO4, PTPN22, IRF5, STAT4, and BLK genes.
• Utilized TaqMan assay and direct sequencing for genetic analysis.
• Compared allele and genotype frequencies, and HLA haplotypes across three patient groups.

Main Results:

• The PTPN22 gene promoter SNP (-1123G > C) was more frequent in T1D patients with ADs (groups A & B) compared to those without (group C).
• The HLA DRB1*0405-DQB1*0401 haplotype was also significantly more common in T1D patients with ADs.
• Other analyzed SNPs showed comparable allele frequencies across groups.

Conclusions:

• The PTPN22 gene promoter SNP and HLA DRB1*0405-DQB1*0401 may contribute to the development of ADs in T1D patients.
• These genetic markers could influence the concurrence of systemic and organ-specific ADs in T1D.
• Highlights potential shared genetic pathways in autoimmune conditions associated with T1D.